• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Dyne Therapeutics shares jump ahead of clinical data review

by January 8, 2025
written by January 8, 2025

Investing.com — Dyne Therapeutics, a biotechnology company, saw its shares rise by up to 10% after the market closed on Wednesday.

The surge in stock price came as the company announced an investor conference call to review new clinical data.

The data is from its ACHIEVE trial, a study focusing on a yet undisclosed treatment. The company has not provided further details on the nature of the trial or the data to be reviewed.

Dyne Therapeutics, which specializes in developing therapies for patients with serious muscle diseases, said the review of the data is scheduled for January 10.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
After-hours movers: NVIDIA, Costco, Penguin Solutions, Avadel Pharma
next post
U.S. Steel CEO appeals to Trump after Biden blocks deal with Japanese firm

You may also like

BASF results down on impairments, restructuring

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Trump implies government could cut contracts and subsidies to Musk’s companies

      June 7, 2025
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (505)
    • Stock (6,426)

    Latest News

    • Trump implies government could cut contracts and subsidies to Musk’s companies
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

    Popular News

    • Big year of central bank easing wraps up with dovish BoE, Fed caution
    • Russia stocks higher at close of trade; MOEX Russia Index up 0.71%

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy